Building upon the foundation of basics discussed in the previous edition, the Second Edition provides a more in-depth look at the latest methods and technologies of advanced drug screening, an essential function of drug discovery.
With extensively updated content and 21 new chapters, this text examines:quality and efficiency of drug target validation and potential drug compound selectionreducing assay costs and improvement in assay technologydata quality improvementtrends in drug discoveryhow drug screening can minimize adverse drug effectsrecent advancements, including: high content screening; protein-protein interactions; high-throughput crystallization; lead optimization; chemoinformatics and microfluidics technologies; target validation by genomics, proteomics, and siRNA; structure-based drug design; automation; and medicinal chemistry
Publisher: Taylor & Francis Inc
Number of pages: 504
Weight: 794 g
Dimensions: 229 x 152 x 33 mm
Edition: 2nd New edition
You may also be interested in...
Would you like to proceed to the App store to download the Waterstones App?